Wikidata

(Q27824835)

English

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

scientific article

In more languages

Statements

title
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group (English)
1 reference
stated in
PubMed
PubMed ID
15911866
retrieved
13 November 2016
author
David Grimes
series ordinal
8
object named as
David Grimes
0 references
Pierfranco Conte
series ordinal
13
object named as
PierFranco Conte
0 references
author name string
Michel Marty
series ordinal
1
0 references
Francesco Cognetti
series ordinal
2
0 references
Dominique Maraninchi
series ordinal
3
0 references
Ray Snyder
series ordinal
4
0 references
Louis Mauriac
series ordinal
5
0 references
Michèle Tubiana-Hulin
series ordinal
6
0 references
Stephen Chan
series ordinal
7
0 references
Antonio Antón
series ordinal
9
0 references
Ana Lluch
series ordinal
10
0 references
John Kennedy
series ordinal
11
0 references
Kenneth O'Byrne
series ordinal
12
0 references
Michael Green
series ordinal
14
0 references
Carol Ward
series ordinal
15
0 references
Karen Mayne
series ordinal
16
0 references
Jean-Marc Extra
series ordinal
17
0 references
publication date
1 July 2005
0 references
volume
23
0 references
page(s)
4265-74
0 references
issue
19
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27824835&oldid=1984568780"